Singulair Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Fluticasone Propionate, Azithromycin, and Montelukast Sodium in Treating Patients With Bronchiolitis Obliterans Who Previously Underwent Stem Cell Transplant
Condition:   Bronchiolitis ObliteransInterventions:   Drug: fluticasone propionate;   Drug: montelukast sodium;   Procedure: pulmonary function testing;   Other: questionnaire administration;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis;   Genetic: protein analysis;   Drug: azithromycinSponsors:   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI)Active, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2011 Category: Research Source Type: clinical trials

First Step With Singulair® Therapy (0476-323)
Condition:   AsthmaInterventions:   Drug: MK0476 (singulair), montelukast sodium / Duration of Treatment: 6 Weeks;   Drug: Comparator: Fluticasone / Duration of Treatment: 6 WeeksSponsor:   Merck Sharp & Dohme Corp.Completed - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2007 Category: Research Source Type: clinical trials